Ethical considerations in HIV preventive vaccine research

Kurzformat

Ethical considerations in HIV preventive vaccine research / Geneva , 2000

48 p.

LEADER	00000nam a22000002c 4500
001	991153550129705501
005	20201225105628.0
008	071121s2000 sz 00\| \| eng\|\|
019			\|a Datenkonversion AIDS Info Doku \|5 IDSBB/12.04.2013/B583
035			\|a (swissbib)065207513-41slsp_network
035			\|a 065207513 \|9 ExL
035			\|a (IDSBB)006112709DSV01
035			\|a (EXLNZ-41SLSP_NETWORK)991153550129705501
035			\|a (41SLSP_UBE)99116749729205511 \|9 (41SLSP_UBE)99116749729205511
040			\|a BAG \|e kids \|d CH-ZuSLS
041	0		\|a eng
245	0	0	\|a Ethical considerations in HIV preventive vaccine research
264		1	\|a Geneva \|b UNAIDS \|b WHO \|c 2000
300			\|a 48 p.
336			\|b txt \|2 rdacontent
337			\|b n \|2 rdamedia
338			\|b nc \|2 rdacarrier
490	0		\|a UNAIDS/WHO guidance document \|v April 2000
520			\|a This document highlights, from UNAID'S perspective, some of the critical elements that must be considered in HIV vaccine development activities
710	2		\|a Joint United Nations Programme on HIV, AIDS \|0 (DE-588)5507703-1
710	2		\|a Weltgesundheitsorganisation \|0 (DE-588)1007857-5
852	4		\|b B583 \|c 583BA \|j IMG BAG GR.2100.047.e \|9 (41SLSP_UBE)99116749729205511
900			\|a IDSIxunikat
949			\|c 583BA \|p 11 \|j IMG BAG GR.2100.047.e \|b B583 \|9 (41SLSP_UBE)99116749729205511
986			\|a (41SLSP_UBE)99116749729205511 \|9 (41SLSP_UBE)99116749729205511
990			\|f BAG AIDSDoku \|9 LOCAL \|9 (41SLSP_UBE)99116749729205511